| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 454.754 | 617.695 | 648.838 | 639.440 | 431.520 | 658.475 | 479.461 | 785.745 | 976.507 | 975.628 |
| Total Income - EUR | 566.344 | 551.287 | 822.337 | 745.571 | 690.265 | 941.792 | 855.103 | 1.218.024 | 1.277.174 | 1.245.953 |
| Total Expenses - EUR | 558.606 | 540.179 | 806.235 | 708.179 | 681.341 | 924.384 | 833.816 | 1.201.864 | 1.269.709 | 1.240.708 |
| Gross Profit/Loss - EUR | 7.738 | 11.108 | 16.103 | 37.392 | 8.924 | 17.408 | 21.287 | 16.160 | 7.465 | 5.245 |
| Net Profit/Loss - EUR | 6.298 | 8.664 | 7.974 | 31.190 | 4.828 | 11.820 | 17.372 | 9.766 | 3.004 | 3.250 |
| Employees | 10 | 9 | 8 | 7 | 8 | 8 | 8 | 8 | 10 | 9 |
Check the financial reports for the company - Bioavis Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 100.342 | 92.445 | 192.699 | 167.203 | 273.988 | 324.329 | 281.980 | 288.120 | 275.602 | 247.509 |
| Current Assets | 229.076 | 198.284 | 141.012 | 219.250 | 339.485 | 396.039 | 642.904 | 655.925 | 547.690 | 419.813 |
| Inventories | 210.917 | 180.404 | 97.641 | 173.595 | 280.272 | 259.403 | 602.546 | 593.539 | 506.815 | 350.293 |
| Receivables | 13.507 | 13.206 | 36.696 | 44.968 | 50.924 | 39.935 | 39.847 | 53.310 | 31.157 | 48.075 |
| Cash | 4.652 | 4.675 | 6.675 | 687 | 8.288 | 96.701 | 510 | 9.076 | 9.718 | 21.445 |
| Shareholders Funds | 12.581 | 21.117 | 28.734 | 59.397 | 63.075 | 73.699 | 85.682 | 95.714 | 98.428 | 101.128 |
| Social Capital | 90 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 317.262 | 269.965 | 305.603 | 327.057 | 550.398 | 646.670 | 839.201 | 848.331 | 724.864 | 566.193 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "147 - 147" | |||||||||
| CAEN Financial Year |
147
|
|||||||||
Comments - Bioavis Srl